Celldex Therapeutics buy Stifel Nicolaus
Start price
18.06.24
/
50%
€33.20
Target price
18.06.25
€54.03
Performance (%)
-10.24%
Price
27.09.24
€29.20
Summary
This prediction is currently active. The prediction for Celldex Therapeutics disappoints with a performance of -10.24%. This prediction currently runs until 18.06.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Celldex Therapeutics | -14.737% | -14.737% |
iShares Core DAX® | 1.518% | 3.456% |
iShares Nasdaq 100 | 1.240% | 2.983% |
iShares Nikkei 225® | 2.808% | 2.743% |
iShares S&P 500 | 0.403% | 2.187% |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat